Ansell Micro-Touch Nitrile Examination Gloves Small (700102)

Ansell Micro-Touch Nitrafree Nitrile Examination XS (5.5-6)

Box (100)   Provides comfortable and reliable protection while supporting breast cancer research   The Micro-Touch Nitrafree Nitrile examination gloves are made from a durable and soft nitrile formulation manufactured without chemical accelerators, helping to protect users from Type IV chemical allergies. Provides comfortable and reliable protection while supporting breast cancer research.   Key Features and Benefits   Manufactured without sulfur-based chemical accelerators, helping to protect users from Type IV chemical allergies While supporting Breast Cancer Research in select regions Thin and light weight to ensure excellent tactility while working Tested for use with chemotherapy drugs Pink Powder-free Textured fingers Non-sterile Cuff Length: Standard Freedom from holes (inspection level 1): 1.5 AQL Glove length (mm/inches): 240 / 9.5 EN 420:2003 + A1:2009 ASTM D6319

Ansell Micro-Touch White Nitrile Gloves Medium (700153) -150

Box (150).Nitrile, powder-free white examination glove with a more robust fit and feelThis non-sterile glove is a standard nitrile formulation. A more robust thickness provides a more substantial fit and feel. An inner polymer coating makes donning easy and the absence of powder considerably reduces the risk of skin abrasions.KEY FEATURES AND BENEFITS:• Effective barrier protection against punctures and a wide range of chemicals• Protects from latex Type I allergy• 150-count packaging reduces waste• Tested for use with chemotherapy drugs** See product packaging or contact Ansell Customer Service for specific chemotherapy drug permeation times and recommendationsWARNING: No glove completely protects against all chemicals. Users should test the suitability of this product against the specific chemicals and environment where used.Recommended ForTested for use with chemotherapy drugsStandard, moderate risk examination proceduresEnvironmentally friendly facilitiesProtection from Type I latex allergy in HCW's or patients